In one word, how would you describe your research?
==================================================

"Translation". The main task of our research effort is the transfer of synthetic methods from organic chemistry into PET chemistry. This should facilitate the accessibility of known PET tracers and, furthermore, enable an accelerated development of novel molecular probes for clinical applications. The primary goal of our research is to improve the efficacy of clinical diagnostics and, ultimately, patient care.

What are the main challenges in the broad area of your research?
================================================================

There are two types of constraints which we are confronted with. The first one is related to a lack of disease-associated molecular targets that could be efficiently used for clinical functional imaging. The second one originates from the properties of typical PET nuclides such as short half-lives (10--120 min). Additionally, application of tracers with high specific activities is often mandatory for the acquisition of diagnostically conclusive images.

Furthermore, syntheses with PET nuclides are challenging due to time and mass restrictions (nanomolar synthesis scale). Moreover, since high levels of radioactivity are manipulated, the automation of radiolabeling procedures is obligatory. Consequently, radiofluorination methods are still rather rare in comparison to fluorination methods used in conventional organic chemistry.

Is your current research mainly driven by curiosity or rather applied?
======================================================================

Curiosity is the most powerful driving force in the development of mankind. Naturally, it is also the main motor in scientific progress. However, our institute is financed by public tax funds. Correspondingly, we always try to apply emerging developments in fundamental research into practically relevant applications (e.g. for clinical use).
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